TABLE 6.
Vaccine strain | Vaccine dose | Time to death (days)c | Median time to death (days) |
---|---|---|---|
Intradermal challengea | |||
None | None | 4, 5, 5, 5, 5 | 5 |
ΔFTL0439 | 10 | >28 (5) | >28 |
ΔfupA | 103 | >28 (5) | >28 |
ΔpdpC ΔpdpE | 107 | 5, 13, >28 (3) | >28 |
FSC043 | 107 | 6, >28 (4) | >28 |
ΔpdpC | 103 | 7, 9, 25, >28 (2) | 25 |
ΔpdpC | 107 | 5, >28 (4) | >28 |
Intranasal challengeb | |||
None | None | 5, 6, 6, 6, 6 | 6 |
ΔFTL0439 | 10 | >28 (5) | >28 |
ΔfupA | 103 | 10, 11, 21, 22, >28 | 21 |
ΔpdpC ΔpdpE | 107 | 7, 8, 8, 9, 10 | 8 |
FSC043 | 107 | 9, 13, 13, >28 (2) | 13 |
ΔpdpC | 103 | 7, 7, 8, 8, 8 | 8 |
ΔpdpC | 107 | 7, 7, 7, 8, 9 | 7 |
Five-week-old immune mice were challenged with 2,400 CFU of strain SCHU S4. The mice were followed for 28 days after challenge.
Five-week-old immune mice were challenged with 25 CFU of strain SCHU S4. The mice were followed for 28 days after challenge.
The numbers in parentheses are the numbers of mice with the preceding time to death when more than 1.